Monthly Prescribing Reference: Statins May Reduce Risk for Hepatocellular Carcinoma in Chronic Liver Disease Long-term use of statins may delay or deflect the development of hepatocellular carcinoma in adults with chronic liver disease, as well as in the general population, emerging research, including ... EurekAlert!: Serum-derived hsa_circ_101555 as a diagnostic biomarker in non-hepatocellular carcinoma chronic liver disease Serum-derived hsa_circ_101555 as a diagnostic biomarker in non-hepatocellular carcinoma chronic liver disease The cervical biopsy was nondiagnostic despite imaging and PET suggesting aggressive disease; a targeted lumbar biopsy ultimately confirmed metastatic hepatocellular carcinoma. The analysis included 16,501 participants: 3610 statin users and 12,891 nonusers.
HealthDay News — For patients with chronic liver disease, statin use is associated with a reduced risk for ... Liver cancer is one of the world's deadliest cancers, and most cases are linked to chronic viral hepatitis. Yet scientists have lacked an animal model that faithfully recapitulates how the disease ... STAT: Risk of dying from chronic disease in the U.S.
chronic hepatocellular disease, declined, but there are caveats, study says Isabella Cueto covers the leading causes of death and disability: chronic diseases. Her focus includes autoimmune conditions and diseases of the lungs, kidneys, liver (and more). She writes about ... Risk of dying from chronic disease in the U.S. declined, but there are caveats, study says
